Pharmaceutical Glass Packaging Market Size

Global Pharmaceutical Glass Packaging Market Overview

The pharmaceutical glass packaging market size was valued at USD 5136.53 million in 2023. The pharmaceutical glass packaging industry is projected to grow from USD 5578.23 million in 2024 to USD 11599.43 million by 2032, exhibiting a compound annual growth rate (CAGR) of 9.6% during the forecast period (2024 - 2032). The growing pharmaceutical industry and inclination towards glass medicines owing to their beneficial features are the key market drivers enhancing the market growth.

Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review

Pharmaceutical Glass Packaging Market Trends

• 
  

  Growing Pharmaceutical Industry to boost the market growth

  
  

Future market expansion for pharmaceutical glass packaging is anticipated to be driven by the growth of the pharmaceutical sector. The research, development, and production of medicines and treatments are part of the pharmaceutical sector. Strong acids, alkalis, and pharmaceutical glass packaging are utilized for packaging and storing these substances. For instance, the Indian pharmaceutical market expanded by 17.7% yearly in 2021, up from 13.7% in July 2020, according to the Indian Brand Equity Foundation, an Indian government organization, and the market revenue is anticipated to be over 12% in 2022. As a result, the pharmaceutical glass packaging market is expanding as the pharmaceutical sector expands.

Technological advancements are the primary trend gaining traction in the pharmaceutical glass packaging market. To strengthen their position in the market, major pharmaceutical logistics companies  are developing new technology. For instance, the Gx Elite vials, which are produced utilizing cutting-edge technology, Gx RHOC systems, were introduced by Gerresheimer, a German maker of pharmaceutical glass packaging and glass injections for patients, in January 2020. This is a brand-new type I borosilicate glass container called a G.X. Elite vial. These glass tubes are top-quality tubular vials. Customers and patients can buy this product with confidence. Therefore, such factors have recently enhanced the market CAGR across the globe in the recent years.

Corning and SGD Pharma inaugurated a new glass tubing facility in June 2023, as well as enhancing accessibility of the Corning Velocity Vial technology into Telangana, India, through a joint venture. By 2024, production of Velocity Vials is expected to begin at SGD Pharma's plant in Vemula (India), while pharma tubing manufacturing is due to start only in 2025.

Bormioli Pharma S.p.A entered a renewed partnership with Desall.com on May 2023 to foster new ideas and innovation regarding pharmaceutical packaging, focusing on enhancing AR solutions for drug delivery and biometric recognition systems transforming child-resistant closures.

Schott AG started manufacturing FIOLAX® amber pharma glass in India in March 2023 so as to meet growing demand for the product within Asia. As such, it will improve reliability, scheduling, availability and cost efficiency for pharmaceutical converters.

In May 2021, Piramida was purchased by Nipro, a Japanese business that deals in glass packaging for pharmaceuticals. The acquisition is anticipated to improve Nipro's production capacity. also contributes to the ampoules and vials business of Nipro. Glass vials and ampoules of the highest quality are produced by the Latvian company Piramida for use in medicinal products. This will be In May 2021, Piramida was purchased by Nipro, a Japanese business that deals in glass packaging for pharmaceuticals. The acquisition is anticipated to improve Nipro's production capacity. It also contributes to the ampoules and vials business of Nipro. Glass vials and ampoules of the highest quality are produced by the Latvian company Piramida for use in medicinal products. This will expand the pharmaceutical glass packaging industry to expand and act as another factor driving the growth of the pharmaceutical glass packaging market revenue.

Pharmaceutical Glass Packaging Market Segment Insights

Pharmaceutical Glass Packaging Product Insights

The pharmaceutical glass packaging market segmentation, based on product, includes vials, bottles & jars, cartridges & syringes, and ampoules. The vials pharmaceutical glass packaging segment held the majority share in 2021 contribution to around ~55-60% in respect to the pharmaceutical glass packaging market revenue.Glass vials are constructed with Type 1 borosilicate glass gives them the appropriate level of chemical resistance. Vials are projected to be the segment with the quickest growth rate due to their high analytical performance and excellent sustainability.

August 2021: Serum Institute of India (SII) buys a 50% stake in SCHOTT Kaisha in order to join SCHOTT in a joint venture and guarantee a supply of pharmaceutical packaging. The joint venture is the top producer of pharmaceutical packaging items in India, including vials, syringes, ampoules, and cartridges used to package life-saving drugs.

Figure 2: Pharmaceutical Glass Packaging Market, by Product, 2021 & 2030 (USD Million)


Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Due to glass's capacity to filter particular wavelengths, its high level of microbiological control, and its superior chemical resistance, the ampoules pharmaceutical glass packaging market that is made primarily of glass is predicted to expand with the most alluring CAGR in terms of revenue during the projection period. Ampoules with sealed, funnel-style, and straight-stem designs are produced in large quantities under DIN ISO EN 9187-1/2 standard.

Pharmaceutical Glass Packaging Application Insights

The pharmaceutical glass packaging market segmentation, based on the application, includes generic drugs, branded drugs, and biological drugs. The market was led by generic drug types of pharmaceutical glass packaging in 2021, accounting for the highest proportion of worldwide revenue. Due to an aging population, an increase in chronic disease cases, and a growth in drug patents that have expired in recent years, the market for generic medications has grown. Additional reasons that are projected to increase the use of generic pharmaceuticals include government and healthcare provider attempts to lower healthcare costs and drug prices, as well as the availability of health insurance. Due to its regulatory simplicity and exceptional barrier properties, the rising use of generic medications is anticipated to enhance demand for pharmaceutical glass packaging. Hence, the rising adoption of generic drug applications positively impacts market growth.

The growth of biologic pharmaceutical glass packaging is mostly attributed to their effectiveness in treating serious chronic diseases, particularly specific types of autoimmune diseases and cancer. The rise of biologic drugs and pharmaceutical glass packaging is expected to be restrained by glass delamination and chipping caused by surface deterioration. Owing to the factors mentioned, biologic drugs is the second fastest-growing segment in the pharmaceutical glass packaging market.

Pharmaceutical Glass Packaging Regional Insights

By region, the study provides the market insights North America, Europe, Asia-Pacific, and the Rest of the World. Asia Pacific market accounted for USD 2005.811 million in 2021 and is anticipated to exhibit a CAGR of 45.80% growth during the study period. Regarding revenue, Asia Pacific is expected to be the largest region. Numerous small and medium-sized industrial facilities in the area are evidence of this increase in demand. Additionally, the region benefits from a lax regulatory environment that helps manufacturers and draws in outside investment. Companies like Corning and Schott AG frequently collaborate with small-scale production facilities in the area to extend their regional presence and increase their market share.

Further, the major countries studied in the market report are: The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Figure 3: PHARMACEUTICAL GLASS PACKAGING MARKET SHARE BY REGION 2021 (%)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

North America pharmaceutical glass packaging market. In the approaching years, the pharmaceutical industry's spending is anticipated to soar in developing markets. With innovative goods driving the growth, the U.S. pharmaceutical glass packaging market is anticipated to remain a significant region and driver for the expansion of the pharmaceutical industry in the area. The increase in generic drugs in the area, which is likely to result in consistently high demand in terms of volume and sales, is anticipated to contribute to this expansion.

The Europe pharmaceutical glass packaging market is anticipated to expand at the fastest CAGR from 2022 to 2030. A major strength of the European economy is the pharmaceutical industry, which is built on research. Due to the expansion of medical research, development, and the launch of new medications aimed at enhancing the health and quality of life of patients in the area, the pharmaceutical glass packaging sector is on the increase. Moreover, Germany pharmaceutical glass packaging market held the largest market share, and the UK pharmaceutical glass packaging market was the fastest growing market in the Europe region

For instance, Germany pharmaceutical glass packaging market is growing. The Federal Association of the German Glass Sector estimates that the country's top 10 glass makers bring in about 20% of the total revenue for the glass industry. The market is currently dominated by a select group of large international glassmakers who are interested in making glass bottles. Hence, Europe is anticipated to register the highest growth rate over the forecast period from 2022–2030.

At the CPHI Barcelona trade show held during November 2023, the manufacturer of primary packaging glass solutions launched their latest eco-friendly PharmaCos line specifically intended for well-being and healthcare products. The PharmaCos line was unveiled at the CPHI show in Barcelona from October 24th to 27th 2023; it boasts different sized amber glass jars with screw neck designs ranging from 5 ml to 500 ml as well as flat-shoulder bottles both in flint glass and amber ranging between 20ml and150ml. Neck finishes on these bottles are available in either GPI22/400 or GPI24/410.

Pharmaceutical Glass Packaging Key Market Players & Competitive Insights

Major market players are investing a lot of time and capital and other financial investments like R&D to improve their product portfolios, which will help the market grow faster. Market participants are also taking a range of both growth initiatives to extend their international reach, with key market developments such as product innovations & new product developments, contractual agreements, mergers & acquisitions, increased investments, and strategic collaboration with other organizations. Competitors in the pharmaceutical glass packaging industry must offer cost-effective items to expand and survive in an increasingly competitive and rising market environment.

One of the primary business strategies adopted by manufacturers in the pharmaceutical glass packaging industry to help clients and expand the market sector is to produce locally to decrease operating expenses. In recent years, pharmaceutical glass packaging industry has provided industries with some of the most significant benefits. The market major player such as Schott AG (Germany), Nipro Corporation (Japan), Piramal Glass (Mumbai), Sisecam Group, Owens-Illinois Inc.(US), and others are working to scale the market demand by investing aggressively in research and development initiatives across pharmaceutical glass packaging.

Berry Global has announced the launch of its BerryHaler, a dual chamber, dry powder inhaler (DPI) that contains a dose counter to better aid patient access and effective delivery of combination medications. It seems that BerryHaler is ready to be tailored for pharmaceutical companies intending to have quick entry into the market in terms of inhalation treatments for relieving symptoms related to Chronic Obstructive Pulmonary Disease (COPD), asthma and other lung diseases. This patented design from the company contains dual chamber Puck properties that facilitates simultaneous administration of 30 doses for double and triple formulas per patient.

Nipro Corporation (Japan) is a leading supplier of glass primary packaging for the pharmaceutical sector. Pre-fillable syringes, vials, cartridges, and ampoules are the Japanese-quality items the company creates and manufactures. In May 2021, The maker of glass pharmaceutical packaging in Croatia, Piramida, was purchased by Nipro Corporation, a Japanese packaging company. With the purchase of Piramida and its annual capacity of more than 500 million glass containers, Nipro is now equipped to meet the market's demands in Central Europe.

List of the Key Companies in the Pharmaceutical Glass Packaging market Include

• 
  

  Schott AG (Germany)

  
  


• 
  

  Nipro Corporation (Japan)

  
  


• 
  

  Piramal Glass (Mumbai)

  
  


• 
  

  Sisecam Group

  
  


• 
  

  Owens-Illinois Inc.(US)

  
  


• 
  

  Gerresheimer AG (Germany)

  
  


• 
  

  SGD Pharma (France)

  
  


• 
  

  Bormioli Pharma S.p.A (Italy)

  
  


• 
  

  Ardagh Group S.A.(Luxembourg)

  
  


• 
  

  West Pharmaceutical Services Inc.(US), among others

  
  

Pharmaceutical Glass Packaging Industry Developments

In November 2023, Corning Incorporated launched Corning Velocity Vials which are specially coated engineered Type I borosilicate vials. These vials have better impact strength than traditional borosilicate vials consequently reducing the likelihood of cracking and breaking.

In June 2023, Müller + Müller, a producer of tubular glass primary packaging materials for pharmaceuticals, invested €15 million at its vial production facility in Holzminden. Up to 14 new production lines, as well as an associated clean room, are included in the investment.

In October 2022, Gerresheimer AG teamed up with Merck to develop a digital solution that will guarantee security and traceability throughout the entire pharmaceutical supply chain. The aim was to create a virtual representation of syringes or vial' packages by means of computerized modeling.
On January-2022, West Pharmaceutical Services Inc. entered into a partnership with Corning to improve drug delivery and drug containment by developing pharmaceutical packaging solutions.

In August 2022, Gerresheimer AG earmarked up to USD 94 million for significantly expanding the supply, logistics, and production capacities of glass vials in the USA, thanks to funding from numerous departments of USA government.

In July 2022, Nipro Corporation Japan set aside HRK 100 million (USD 13.6 million/EUR 13.3 million) for Croatia's new glass packaging factory that manufactures drugs' life-saving ampoules and vials in its Pharmaceutical Division Nipro PharmaPackaging located at Sesvete near Zagreb.

Pharmaceutical Glass Packaging Product Outlook

• 
  

  Vials

  
  


• 
  

  Bottles & Jars

  
  


• 
  

  Cartridges & Syringes

  
  


• 
  

  Ampoules

  
  

Pharmaceutical Glass Packaging Application Outlook

• 
  

  Generic Drugs

  
  


• 
  

  Branded Drugs

  
  


• 
  

  Biological Drugs

  
  

Pharmaceutical Glass Packaging Regional Outlook

• 
  

  North America

  
  
  
  
  • 
    

    US

    
    
  
  
  • 
    

    Canada

    
    
  
  
  
  


• 
  

  Europe

  
  
  
  
  • 
    

    Germany

    
    
  
  
  • 
    

    France

    
    
  
  
  • 
    

    UK

    
    
  
  
  • 
    

    Italy

    
    
  
  
  • 
    

    Spain

    
    
  
  
  • 
    

    Rest of Europe

    
    
  
  
  
  


• 
  

  Asia-Pacific

  
  
  
  
  • 
    

    China

    
    
  
  
  • 
    

    Japan

    
    
  
  
  • 
    

    India

    
    
  
  
  • 
    

    Australia

    
    
  
  
  • 
    

    South Korea

    
    
  
  
  • 
    

    Australia

    
    
  
  
  • 
    

    Rest of Asia-Pacific

    
    
  
  
  
  


• 
  

  Rest of the World

  
  
  
  
  • 
    

    Middle East

    
    
  
  
  • 
    

    Africa

    
    
  
  
  • 
    

    Latin America